Alemtuzumab

Alemtuzumab (marketed as Campath, MabCampath or Campath-1H) is a monoclonal antibody used in the treatment of chronic lymphocytic leukemia (CLL) and T-cell lymphoma. Alemtuzumab targets CD52, a protein present on the surface of mature lymphocytes, but not on the stem cells from which these lymphocytes were derived. It is used as second line therapy for CLL. It was...
Read article at Wikipedia

Drug

Show more data

Edit and Show details

Add or delete facts, expose empty fields, download data in JSON or RDF formats, and explore topic metadata.

Freebase Logo
What is Freebase?

Freebase is a huge collection of facts, built by people like you. Freebase connects facts in ways other sites can't, giving you new ways to explore millions of subjects.
You can help improve it!

Flag this Topic
Why do you want to flag this topic?
Freebase Attribution

Freebase data is free for use under the CC-BY license.

The original description for this topic was automatically generated from the Wikipedia article "Alemtuzumab" licensed under the GNU Free Documentation License .
Learn more about Freebase licensing and attribution